- Home
- Publications
- Publication Search
- Publication Details
Title
Novel Levodopa Formulations for Parkinson’s Disease
Authors
Keywords
Levodopa, Entacapone, Motor Fluctuation, Carbidopa, Oral Levodopa
Journal
CNS DRUGS
Volume 30, Issue 11, Pages 1079-1095
Publisher
Springer Nature
Online
2016-10-14
DOI
10.1007/s40263-016-0386-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical Pharmacokinetics of IPX066
- (2016) Hsuan-Ming Yao et al. CLINICAL NEUROPHARMACOLOGY
- A randomized trial of inhaled levodopa (CVT-301) for motor fluctuations in Parkinson's disease
- (2016) Peter A. LeWitt et al. MOVEMENT DISORDERS
- Advances in levodopa therapy for Parkinson disease
- (2016) Rohit Dhall et al. NEUROLOGY
- Carbidopa/Levodopa ER Capsules (Rytary®, Numient™): A Review in Parkinson’s Disease
- (2015) Sarah L. Greig et al. CNS DRUGS
- Long-Term Treatment with Extended-Release Carbidopa–Levodopa (IPX066) in Early and Advanced Parkinson’s Disease: A 9-Month Open-Label Extension Trial
- (2015) Cheryl H. Waters et al. CNS DRUGS
- The Benzodiazepine–Dementia Disorders Link: Current State of Knowledge
- (2015) Antoine Pariente et al. CNS DRUGS
- A levodopa dry powder inhaler for the treatment of Parkinson’s disease patients in off periods
- (2015) Marianne Luinstra et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Carbidopa levodopa enteral suspension
- (2015) Lauren C Seeberger et al. EXPERT OPINION ON PHARMACOTHERAPY
- Comparison of the pharmacokinetics of an oral extended-release capsule formulation of carbidopa-levodopa (IPX066) with immediate-release carbidopa-levodopa (Sinemet®), sustained-release carbidopa-levodopa (Sinemet® CR), and carbidopa-levodopa-entacapone (
- (2015) Ann Hsu et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Gastroretentive carbidopa/levodopa, DM-1992, for the treatment of advanced Parkinson's disease
- (2015) Leo Verhagen Metman et al. MOVEMENT DISORDERS
- Global long-term study on motor and non-motor symptoms and safety of levodopa-carbidopa intestinal gel in routine care of advanced Parkinson's disease patients; 12-month interim outcomes
- (2015) Angelo Antonini et al. PARKINSONISM & RELATED DISORDERS
- Conversion to IPX066 from Standard Levodopa Formulations in Advanced Parkinson’s Disease: Experience in Clinical Trials
- (2015) Paul A. Nausieda et al. Journal of Parkinsons Disease
- Population pharmacokinetics of levodopa in subjects with advanced Parkinson's disease: levodopa-carbidopa intestinal gel infusionvs. oral tablets
- (2014) Ahmed A. Othman et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Subacute peripheral neuropathy under duodopa therapy without cobalamin deficiency and despite supplementation
- (2014) Sophie M. Lehnerer et al. JOURNAL OF NEURAL TRANSMISSION
- Polyneuropathy associated with duodenal infusion of levodopa in Parkinson's disease: features, pathogenesis and management
- (2014) Antonino Uncini et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Levodopa-carbidopa intestinal gel in advanced Parkinson's disease: Final 12-month, open-label results
- (2014) Hubert H. Fernandez et al. MOVEMENT DISORDERS
- Comparison of IPX066 with carbidopa–levodopa plus entacapone in advanced PD patients
- (2014) Fabrizio Stocchi et al. PARKINSONISM & RELATED DISORDERS
- Levodopa/carbidopa intestinal gel infusion in advanced Parkinson's disease: a 7-year experience
- (2013) M. Zibetti et al. EUROPEAN JOURNAL OF NEUROLOGY
- Population Pharmacodynamics of IPX066: An Oral Extended-Release Capsule Formulation of Carbidopa-Levodopa, and Immediate-Release Carbidopa-Levodopa in Patients With Advanced Parkinson's Disease
- (2013) Zhongping Mao et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Extended-release carbidopa-levodopa (IPX066) compared with immediate-release carbidopa-levodopa in patients with Parkinson's disease and motor fluctuations: a phase 3 randomised, double-blind trial
- (2013) Robert A Hauser et al. LANCET NEUROLOGY
- Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study
- (2013) C Warren Olanow et al. LANCET NEUROLOGY
- Double-blind study of the actively transported levodopa prodrug XP21279 in Parkinson's disease
- (2013) Peter A. LeWitt et al. MOVEMENT DISORDERS
- Levodopa–carbidopa intestinal gel in advanced Parkinson's disease open-label study: Interim results
- (2013) Hubert H. Fernandez et al. PARKINSONISM & RELATED DISORDERS
- Randomized trial of IPX066, carbidopa/levodopa extended release, in early Parkinson's disease
- (2013) Rajesh Pahwa et al. PARKINSONISM & RELATED DISORDERS
- Prevalence and features of peripheral neuropathy in Parkinson's disease patients under different therapeutic regimens
- (2013) F. Mancini et al. PARKINSONISM & RELATED DISORDERS
- Guillain–Barre/CIDP-like neuropathy in two parkinsonian patients following intestinal levodopa/carbidopa treatment
- (2013) Imke Galazky et al. PARKINSONISM & RELATED DISORDERS
- Neuropathy in Parkinson’s Disease Patients with Intestinal Levodopa Infusion versus Oral Drugs
- (2013) Constanze Jugel et al. PLoS One
- Pharmacokinetics of Levodopa, Carbidopa, and 3-O-Methyldopa Following 16-hour Jejunal Infusion of Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson’s Disease Patients
- (2012) Dag Nyholm et al. AAPS Journal
- Actively Transported Levodopa Prodrug XP21279
- (2012) Peter A. LeWitt et al. CLINICAL NEUROPHARMACOLOGY
- Pharmacokinetics and Pharmacodynamics of Gastroretentive Delivery of Levodopa/Carbidopa in Patients With Parkinson Disease
- (2012) Cuiping Chen et al. CLINICAL NEUROPHARMACOLOGY
- Long-term duodenal levodopa infusion in Parkinson’s disease: a 3-year motor and cognitive follow-up study
- (2012) Maurizio Zibetti et al. JOURNAL OF NEUROLOGY
- β-amyloid and postural instability and gait difficulty in Parkinson's disease at risk for dementia
- (2012) Martijn L.T.M. Müller et al. MOVEMENT DISORDERS
- Advances in gastro retentive drug-delivery systems
- (2011) Pascal Prinderre et al. Expert Opinion on Drug Delivery
- Pharmacokinetics of Levodopa/Carbidopa Delivered From Gastric-Retentive Extended-Release Formulations in Patients With Parkinson's Disease
- (2011) Cuiping Chen et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Crossover comparison of IPX066 and a standard levodopa formulation in advanced Parkinson's disease
- (2011) Robert A. Hauser et al. MOVEMENT DISORDERS
- A brief history of levodopa
- (2010) Oleh Hornykiewicz JOURNAL OF NEUROLOGY
- Pharmacokinetics of levodopa
- (2010) Manuela Contin et al. JOURNAL OF NEUROLOGY
- Subacute axonal neuropathy in Parkinson's disease with cobalamin and vitamin B6 deficiency under duodopa therapy
- (2010) Peter P. Urban et al. MOVEMENT DISORDERS
- Reversible encephalopathy and axonal neuropathy in Parkinson's disease during duodopa therapy
- (2009) Davide Manca et al. MOVEMENT DISORDERS
- Intermittent Subcutaneous Apomorphine Therapy for ???Off??? Episodes in Parkinson??s Disease
- (2008) Richard M Trosch et al. CNS DRUGS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started